Bausch Health Stock Soared By 20%: What To Do Now
Monday, June 27, 2022 6:30 AM EDT
Market conditions are poor for Bausch. Investors have other biotechnology companies to consider instead, such as Horizon Therapeutics which has better growth prospects.